Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rosh K.V. Sethi"'
Autor:
Robert I. Haddad, Ravindra Uppaluri, Ann Marie Egloff, Cloud P. Paweletz, Megan E. Cavanaugh, Anupam M. Desai, Peter C. Everett, Roy B. Tishler, Danielle N. Margalit, Jonathan D. Schoenfeld, Jochen H. Lorch, Rosh K.V. Sethi, Eleni M. Rettig, Jason I. Kass, Laura A. Goguen, Donald J. Annino, Patrick H. Lizotte, Michelle Flynn, Jennifer M. Cutler, Charles T. Quinn, Vickie Y. Jo, Kristine Wong, Kee-Young Shin, Anne O'Neill, Glenn J. Hanna
Purpose:Surgery often represents the best chance for disease control in locoregionally recurrent squamous cell carcinoma of the head and neck (SCCHN). We investigated dual immune-checkpoint inhibition [anti–PD-1, nivolumab (N), and anti-KIR, lirilu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf420cd615480116b990e2ed61fcdd0
https://doi.org/10.1158/1078-0432.c.6530928.v1
https://doi.org/10.1158/1078-0432.c.6530928.v1
Autor:
Robert I. Haddad, Ravindra Uppaluri, Ann Marie Egloff, Cloud P. Paweletz, Megan E. Cavanaugh, Anupam M. Desai, Peter C. Everett, Roy B. Tishler, Danielle N. Margalit, Jonathan D. Schoenfeld, Jochen H. Lorch, Rosh K.V. Sethi, Eleni M. Rettig, Jason I. Kass, Laura A. Goguen, Donald J. Annino, Patrick H. Lizotte, Michelle Flynn, Jennifer M. Cutler, Charles T. Quinn, Vickie Y. Jo, Kristine Wong, Kee-Young Shin, Anne O'Neill, Glenn J. Hanna
Supplementary Data from Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16223d47d6a6a5a0f6e24e31f82882cf
https://doi.org/10.1158/1078-0432.22482441
https://doi.org/10.1158/1078-0432.22482441
Publikováno v:
Journal of General Internal Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ecacc2a740472189e2b16faeea8320
http://europepmc.org/articles/PMC8759432
http://europepmc.org/articles/PMC8759432
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
Health care costs can present a significant strain on patients with head and neck cancer. It remains unclear how much prices may vary among hospitals providing care and what factors lead to differences in prices of surgical procedures. A cross-sectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ad3e876b5fe1830ec7bc4301524fdf5
https://pubmed.ncbi.nlm.nih.gov/35671092
https://pubmed.ncbi.nlm.nih.gov/35671092
Autor:
Tara E. Mokhtari, Chloe Warinner, Heather Edwards, Annie W. Chan, Don Annino, Jonathan D. Schoenfeld, Rosh K.V. Sethi, Eleni M. Rettig
Publikováno v:
American journal of otolaryngology. 43(3)
Most human papillomavirus (HPV)-positive carcinomas of unknown primary (CUP) in the cervical lymph nodes are ultimately found to arise from the oropharynx, which has by far the highest prevalence of HPV-positivity among head and neck tumors. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::670489089b716a90c749ef5075dbca49
https://pubmed.ncbi.nlm.nih.gov/35453094
https://pubmed.ncbi.nlm.nih.gov/35453094